Novolin 70/30
Name: Novolin 70/30
What is the most important information I should know about Novolin 70/30 (insulin isophane and insulin regular)?
Never share an injection pen or syringe with another person, even if the needle has been changed.
What should I discuss with my healthcare provider before using Novolin 70/30 (insulin isophane and insulin regular)?
You should not use this medicine if you are allergic to insulin, or if you are having an episode of hypoglycemia (low blood sugar).
Insulin isophane and insulin regular is not approved for use by anyone younger than 18 years old.
To make sure this medicine is safe for you, tell your doctor if you have:
-
liver or kidney disease; or
-
low levels of potassium in your blood (hypokalemia).
Tell your doctor if you also take pioglitazone or rosiglitazone (sometimes contained in combinations with glimepiride or metformin). Taking certain oral diabetes medicines while you are using insulin may increase your risk of serious heart problems.
Follow your doctor's instructions about using insulin if you are pregnant or breast-feeding a baby. Blood sugar control is very important during pregnancy, and your dose needs may be different during each trimester of pregnancy. Your dose needs may also be different while you are breast-feeding.
What happens if I miss a dose?
Since this medicine is used with a meal, you may not be on a timed dosing schedule. Whenever you use this insulin, be sure to eat a meal within 45 minutes. Do not use extra medicine to make up a missed dose.
Keep insulin on hand at all times. Get your prescription refilled before you run out of medicine completely.
Principal Display Panel - InnoLet
Novolin® 70/30 InnoLet®3 mL
70% NPH, Human Insulin Isophane Suspension and
30% Regular, Human Insulin Injection
(recombinant DNA origin)
NDC 0169-2317-21
List 231721
100 units/mL (U-100)
5x3 mL InnoLet Prefilled Syringes
Keep in cold place between 36° - 46°F (2° - 8°C)
Avoid freezing
NOVOLIN 70/30 human insulin injection, suspension | ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
|
NOVOLIN 70/30 human insulin injection, suspension | ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
|
NOVOLIN 70/30 human insulin injection, suspension | ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
|
Labeler - Novo Nordisk (622920320) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Novo Nordisk Pharmaceuticals Industries Inc. | 622920320 | MANUFACTURE |
Establishment | |||
Name | Address | ID/FEI | Operations |
Novo Nordisk A/S | 312296002 | MANUFACTURE |